Your trusted source for investing success

Tag: trials

FREE Report - How Will Trump Affect Your Gold Investments? 

Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.

Click here to get your free report!

Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.

 
5 Top Nickel Stocks of 2017

5 Top Nickel Stocks of 2017

Nickel prices have been inconsistent in 2017, but some nickel companies have seen share price gains. Here are the five top nickel stocks so far this year.

InspireMD Announces Distribution Agreement for MGuard Prime™ in Chile

InspireMD (NYSE:NSPR) has announced it has signed an agreement with CorpMedical Chile Ltda to distribute the MGuard Prime Embolic Protection System for the treatment of acute coronary syndromes.

As quoted in the press release:
Mr. Jaime Kehr, Chief Executive Officer of CorpMedical Chile Ltda, noted, “MGuard Prime™ with its MicroNet™ technology is

Licensed Producers Are Going Global, But This One Stands Out

Licensed Producers Are Going Global, But This One Stands Out

CFN Media Group (“CannabisFN”), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering Harvest One Cannabis Inc.(TSXV:HVST) tremendous progress in growing its international footprint. The company’s wholly-owned United Greeneries subsidiary is awaiting approval from Health Canada for its ACMPR license to sell, but its

SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI)

SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI)

SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI).

The note is available here: DMPI October 2017 Update.

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI)) is a clinical-stage biotechnology firm

dynaCERT Announces Proprietary Greenhouse Gas Tracking System

dynaCERT Announces Proprietary Greenhouse Gas Tracking System

dynaCERT Inc. (TSXV:DYA; OTC:DYFSF) (“dynaCERT” or the “Company”)  is pleased to announce that it has successfully filed a Provisional Patent Application in the United States for the following patent: “Systems and Methods for Tracking Greenhouse Gas Emissions Associated With an Entity”.
Our system incorporates dynaCERT’s proprietary technology which has been developed after years of extensive

Harvest One provides Update on subsidiary Satipharm and Sales License

Harvest One provides Update on subsidiary Satipharm and Sales License

Harvest One Cannabis Inc.(TSXV:HVST)  is pleased to provide a market update on its wholly owned subsidiary, Satipharm AG (“Satipharm”):

Satipharm has received German “Free Sales Certificate” reducing constraints for international export
Australian Regulatory Authority has issued final approval for CBD capsule prescription in Australia
Strong increase in European dietary supplement

FREE Report - How Will Trump Affect Your Gold Investments? 

Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.

Click here to get your free report!

Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.

 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
22nd Century Group Shares Production Update

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/22nd-century-group-shares-production-update/